Adjuvant capecitabine chemotherapy using a tailored-dose strategy in elderly patients with colon cancer.

Chang, H J; Lee, K-W; Kim, J H; Bang, S M; Kim, Y J; Kim, D W; Kang, S B; Lee, J S

Chang, H J; Lee, K-W; Kim, J H; Bang, S M; Kim, Y J; Kim, D W; Kang, S B; Lee, J S.

Affiliation

Chang HJ; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.

Ann Oncol ; 23(4): 911-8, 2012 Apr.

Article in En | MEDLINE | ID: mdl-21821549

Subject(s)

Adenocarcinoma/drug therapy; Antimetabolites, Antineoplastic/therapeutic use; Colonic Neoplasms/drug therapy; Deoxycytidine/analogs & derivatives; Fluorouracil/analogs & derivatives; Adenocarcinoma/mortality; Aged; Aged, 80 and over; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms/mortality; Deoxycytidine/therapeutic use; Disease-Free Survival; Drug Dosage Calculations; Female; Fluorouracil/therapeutic use; Humans; Kaplan-Meier Estimate; Male; Multivariate Analysis; Quality of Life; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adenocarcinoma / Colonic Neoplasms / Deoxycytidine / Fluorouracil / Antimetabolites, Antineoplastic Type of study: Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2012 Type: Article Affiliation country: South Korea

Fulltext

XML

PubMed Links

Search on Google